Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, 149 13th Street, Room 5406, Charlestown, Massachusetts 02129, USA.
J Org Chem. 2009 Aug 21;74(16):5894-901. doi: 10.1021/jo900832y.
The ability to localize agents to specific anatomic sites remains an important aspect in designing more efficient therapeutics. Light-activated therapies, in particular, allow for the focal ablation of target tissues and cells. In order to increase the specificity of these agents, stimuli-activated systems have been developed, which are nonphototoxic in the absence of activation. To this end, we propose a novel paradigm for excited state quenching and activation based upon the direct conjugation of quenching moieties to the porphyrinic macrocycle. Model compounds, based upon meso-(p-aminophenyl)porphyrins were synthesized bearing 1 to 4 sulfonamide-linked 2,4-dinitrobenzene. The singlet oxygen and fluorescence quantum yields of these compounds were obtained and compared, as well as the kinetics of activation with relevant activating agents. In addition, methods were developed to further modify the porphyrin in order to modulate the polarity and effect conjugation to biomolecules or nanoparticulate scaffolds. These systems may prove useful in the treatment of a number of disease states, such as cancer and bacterial infection.
将药物靶向特定解剖部位的能力仍然是设计更有效的治疗方法的一个重要方面。光激活疗法,特别是,允许目标组织和细胞的焦点消融。为了提高这些药物的特异性,已经开发了刺激激活系统,在没有激活的情况下是非光毒性的。为此,我们提出了一种基于卟啉大环直接共轭淬灭部分的激发态猝灭和激活的新范例。基于间-(对氨基苯基)卟啉的模型化合物被合成,带有 1 至 4 个磺酰胺连接的 2,4-二硝基苯。获得了这些化合物的单线态氧和荧光量子产率,并进行了比较,以及与相关激活剂的激活动力学。此外,还开发了进一步修饰卟啉的方法,以调节极性并影响与生物分子或纳米颗粒支架的共轭。这些系统在治疗许多疾病状态(如癌症和细菌感染)方面可能证明是有用的。